Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Short Communications

Reliability in the Classification of Advanced Colorectal Adenomas

Mary Beth Terry, Alfred I. Neugut, Roberd M. Bostick, John D. Potter, Robert W. Haile and Cecilia M. Fenoglio-Preiser
Mary Beth Terry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfred I. Neugut
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberd M. Bostick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John D. Potter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert W. Haile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia M. Fenoglio-Preiser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published July 2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

In conjunction with a pooled analysis of risk factors for advanced adenomas [adenomas with severe dysplasia, carcinoma in situ (CIS), and intramucosal carcinoma], we undertook a reliability study on the pathological diagnosis of advanced adenomas. We assessed intraobserver agreement (using Kappa (κ) as the measure of agreement) across two time periods 10 years apart with a single pathologist and interobserver agreement (using Kappa) between two pathologists rating the same slides concurrently. The study pathologists were blinded to the original case classification. We used the slides of 190 colorectal adenomatous polyp cases (104 originally diagnosed as advanced adenomas, 86 adenomas without advanced lesions) from a colonoscopy-based case-control study conducted in New York City between 1986 and 1988. We also assessed conditional agreement for 71 slides of advanced adenomas from four adenoma case-control studies conducted in different geographic regions of the United States in the 1990s. Intra- and interobserver agreement was only fair to moderate on the classification of both histological type (villous, tubulovillous, and tubular: intraobserver κ = 0.28; 95% confidence interval (CI), 0.17–0.39; interobserver κ = 0.48; 95% CI, 0.33–0.62) and degree of dysplasia (none/mild, moderate, severe, CIS, and intramucosal: intraobserver κ = 0.20; 95% CI, 0.12–0.28; interobserver κ = 0.42; 95% CI, 0.29–0.55). Using broader, rather than finer, classifications for degree of dysplasia substantially improved the reliability (interobserver agreement for high-grade dysplasia (including severe dysplasia, CIS, and intramucosal carcinoma) versus low-grade dysplasia: κ = 0.69; 95% CI, 0.55–0.83). These findings suggest that future epidemiological studies of advanced adenomas should use broad categories, such as high-grade versus low-grade dysplasia, include central review of all slides, and take measurement error into account in sample size calculations.

  • Received November 12, 2001.
  • Revision received March 22, 2002.
  • Accepted April 3, 2002.
View Full Text
PreviousNext
Back to top
July 2002
Volume 11, Issue 7
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Reliability in the Classification of Advanced Colorectal Adenomas
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Reliability in the Classification of Advanced Colorectal Adenomas
Mary Beth Terry, Alfred I. Neugut, Roberd M. Bostick, John D. Potter, Robert W. Haile and Cecilia M. Fenoglio-Preiser
Cancer Epidemiol Biomarkers Prev July 1 2002 (11) (7) 660-663;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reliability in the Classification of Advanced Colorectal Adenomas
Mary Beth Terry, Alfred I. Neugut, Roberd M. Bostick, John D. Potter, Robert W. Haile and Cecilia M. Fenoglio-Preiser
Cancer Epidemiol Biomarkers Prev July 1 2002 (11) (7) 660-663;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Cancer Predisposition Gene Mutations and Pancreatic Cancer
  • Statin Use and Breast Cancer Risk
  • Tamoxifen and Longitudinal Mammographic Density Change
Show more Short Communications
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement